A Study Testing the Elana Device for Multi-Artery Heart Bypass Surgery
NCT07005843 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2025-06-05
Summary
The purpose of the trial is to evaluate the feasibility and safety of multiple Elana Anastomotic Systems to anastomose multiple arterial grafts during coronary artery bypass grafting (CABG). In the first trial performed with the Elana Anastomotic System, the SAFE-CAB trial, only a single anastomosis with the left internal mammary artery (LIMA) was created with the system to the left anterior descending (LAD) coronary artery or a large Diagonal side-branch of the LAD. This is the most important bypass for patients, often described as the anastomosis that guarantees the survival of patients.
However, often multiple anastomoses need to be created during bypass surgery. In the previous study, those anastomoses were performed using vein grafts with standard-of-care hand-sewn techniques. A large body of evidence exists indicating that arterial grafts provide better long-term outcomes for patients undergoing CABG procedures, mainly using the right internal mammary artery (RIMA), but also the Radial Artery, for anastomosis to the Circumflex (Cx) artery and sometimes the Right Coronary Artery. With assurance of safety and effectiveness of the Elena Anastomotic System for LIMA-to-LAD anastomoses and the similarity of the LIMA-to-LAD anastomosis to other arterial anastomoses (e.g., RIMA-to-Cx and RA-to-RCA) as a result of similar vessel diameters and anatomical features, the Elana Anastomotic System is considered to be suitable for multi-arterial bypass procedures.
Therefore, this study aims to expand on the evidence of using the Elana Anastomotic System in a more complete multi-arterial CABG operation, where two or three anastomoses will be created with the Elana Anastomotic System in order to present a more comprehensive solution.
Conditions
- Coronary Artery Bypass Grafting (CABG) Surgery
Interventions
- DEVICE
-
The Elana Anastomotic System
The Elana Anastomotic System is a medical device and is intended to create a suture less blood vessel anastomosis in Coronary Artery Bypass Grafting (CABG) procedures on the beating heart, without blo
Sponsors & Collaborators
-
AMT Medical BV
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2028-09-30
- Completion
- 2028-12-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
NCT00042081 ·Status: COMPLETED ·Phase: PHASE3
-
A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon
NCT01285271 ·Status: COMPLETED ·Phase: PHASE3
-
One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery
NCT02823054 ·Status: UNKNOWN ·Phase: NA
-
Total Arterial vs. Mixed Grafting in Left Coronary CABG
NCT07057713 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Long-term Comparison of Stenting Versus Off-pump Coronary Bypass Surgery
NCT00975858 ·Status: COMPLETED ·Phase: NA
-
Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients
NCT05889494 ·Status: COMPLETED ·Phase: NA
-
Patency-Coronary Trial
NCT01414049 ·Status: UNKNOWN ·Phase: NA
-
CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)
NCT07165678 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Long LIMA Patch on Left Anterior Descending Coronary Artery in CABG
NCT06173609 ·Status: NOT_YET_RECRUITING
-
Association Between GalectiN-3 and POSt-operative AtrIal Fibrillation After Coronary Artery BypaSs Graft
NCT06768528 ·Status: RECRUITING
-
Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass
NCT02775123 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Post Coronary Artery Bypass Graft (CABG) Study
NCT00000463 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia
NCT00524901 ·Status: COMPLETED ·Phase: PHASE2
-
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
NCT00316212 ·Status: TERMINATED ·Phase: PHASE2
-
CABG Combined Pedicled Omentum Wrapped Autologous Atrial Tissue Patch Cardiomyoplasty for Ischemic Cardiomyopathy
NCT00972114 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
NCT07271615 ·Status: RECRUITING ·Phase: NA
-
A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
NCT00364390 ·Status: UNKNOWN ·Phase: PHASE1
-
Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease
NCT01443754 ·Status: TERMINATED
-
Saphenous Vein Allografts for Coronary Bypass
NCT01386021 ·Status: COMPLETED
-
Xenon in Off-pump Coronary Artery Bypass Graft Surgery
NCT01757106 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Graft Material in Coronary Artery Bypass Grafting (CABG)
NCT01310725 ·Status: COMPLETED ·Phase: NA
-
Comparison of Bidirectional Palpation Test and Transit Time Flow Measurement for LIMA-LAD Graft Patency
NCT06934993 ·Status: COMPLETED
-
Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronary Artery Bypass Grafting
NCT07314138 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Robotically-assisted Minimally-invasive Direct Coronary Artery Bypass With Stenting, Randomized Against Coronary Artery Bypass Graft Surgery
NCT06378775 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia
NCT02303704 ·Status: COMPLETED ·Phase: PHASE2